30th
November 2018 - Global
Proton Therapy Systems Market is segmented by Geographical Region into North
America, Asia-Pacific, Europe, and Rest of the World. Protons are atoms that
carrying positive charge. Just as X-Rays (also known as photons) are used for
treating both - malignant and benign tumors, proton beams can be used for
irradiating tumors Though, protons deliver a dose of radiation in a much more
confined way to the tumor tissue than photons (X-Rays). After they enter the body, protons release
most of their energy within the tumor region and, unlike photons, deliver only
a minimal dose beyond the tumor boundaries. Therefore, predominantly for
smaller tumor sizes, the dose of radiation may reproduce much tighter to the
tumor and there may be less damage to healthy tissue.
Browse Full
Research Report @ https://www.millioninsights.com/industry-reports/proton-therapy-systems-market
As a result, the treating physician (a radiation oncologist) can
potentially give an even greater dose to the tumor while minimizing unwelcome
side effects. This is especially important when treating children, because
protons help reduce radiation to growing and developing tissues in the proton
therapy systems market. Proton therapy delivers radiation to tumor tissue in a
much more confined way than conventional photon therapy thus permitting the
radiation oncologist to use a greater dose while still minimizing side effects.
If you’re programmed for proton therapy, you will likely undergo a
treatment simulation session in which you will be fitted into an immobilization
device to ensure you uphold the same exact position for every treatment. A CT
scan will be attained to create a virtual model of your tumor, and other
imaging procedures may be used to help control its exact shape and location.
Your doctor will give you specific instructions based on the type of exam being
performed.
As proton therapy becomes additional extensively obtainable, imaging for
the development of proton treatment plans will become more common. However,
there are major alterations in how treatment is planned for proton therapy
associated to conventional radiation therapy. Proton Therapy Systems Market is
segmented by Application into Brain cancer, Head & Neck cancer, Sarcoma,
Gastro-intestinal cancer, Pediatric cancer, Lung cancer, and prostate cancer.
Proton therapy applications are more inclined towards gastro-intestinal
and lung cancer due to recommendations by healthcare professionals. Moreover,
proton therapy is also considered to be comparatively safer in case of
pediatric patients suffering from cancer. These applications are expected to
drive the market for proton therapy devices in the upcoming years.
Proton Therapy Systems Market is segmented geographically into North
America and Europe; which are the major markets as majority of the centers
allowing proton therapy. In Asia-Pacific, the market is foretold to grow with
the opening of new centers in Australia and under the effect of cumulative
awareness about the welfares of this progression treatment. The high-priced
cost of theory is one of the main contests to the development of this market.
Proton Therapy Systems Market Key Players include IBA, Varian Technologies,
Hitachi, Mitsubishi Electric, Sumitomo Heavy, ProTom International, Mevion,
ProNova and Company 9.
Request a Free
Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/proton-therapy-systems-market/request-sample
Comments
Post a Comment